EPISODE · Nov 18, 2022 · 15 MIN
Stem Cell Transplant Versus DMTs & DMTs Ease SPMS Disability Early
from MS News & Perspectives · host MS News Today
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article on how stem cell transplant is superior to Gilenya and Tysabri at preventing relapses and easing disability in RRMS patients. He also reads another report on how early use of DMTs may lead to lower levels of disability but does not appear to slow disability progression over time.=================================== Are you interested in learning more about multiple sclerosis? If so, please visit:https://multiplesclerosisnewstoday.com/=====================================To join in on conversations regarding multiple sclerosis, please visit:https://multiplesclerosisnewstoday.com/forums/
Embed this episode
NOW PLAYING
Stem Cell Transplant Versus DMTs & DMTs Ease SPMS Disability Early
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.